Results

Total Results: 600 records

Showing results for "cardiac".
Users also searched for: ekg

221. Attention Deficit Hyperactivity Disorder (ADHD) | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/adhd-update/research-protocol
     October 01, 2019 - disturbance, gastrointestinal symptoms, elevated blood pressure, increased heart rate, risk of sudden cardiac … death, cardiac arrhythmias, conduction abnormalities, tics or other movement disorders, behavior changes … disturbance, gastrointestinal symptoms, elevated blood pressure, increased heart rate, risk of sudden cardiac … death, cardiac arrhythmias, conduction abnormalities, tics or other movement disorders, behavior changes … death Cardiac arrhythmias Conduction abnormalities Tics or other movement disorders Behavior

222. Final_multivariate_v22_CLEAN_03-11-2013 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-binary-outcomes-evaluation_research.pdf
     March 11, 2013 - The usual approach is to perform two separate meta-analyses: one for cardiac mortality and one for … In the previous example, if too many people die of cardiac causes, fewer people are at risk of dying … events by 6 months 2, 2 Major adverse cardiac events by 12 months 15 (6325) 6 (1978) 1 (605) … disease, in the STRATEGY trial, the number of major cardiac events was the same at 6 months and 12 … The outcomes of interest are the number of major cardiac events at 6 and 12 months.

223. Measuring-Blood-Pressure Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure_executive.pdf
     January 01, 2012 - with usual care or other interventions without SMBP in its effect on relevant surrogate outcomes (cardiac … to the link between the intermediate outcome blood pressure control and either surrogate outcomes (cardiac … Mortality > CVC events > Patient satisfaction > Quality of life > Treatment AE Surrogate outcomes > Cardiac … with usual care or other interventions without SMBP in its effect on relevant surrogate outcomes (cardiac … visits, 2 reported on hospital admissions or inpatient or urgent care/emergency use, and 3 reported on cardiac

224. PICO #1 Population(s): Children with infantile hemangiomas (IHs) Intervention(s): Early referral Comparator(s): Delayed referral Outcomes(s): Minimization of functional impairment and/or cosmetic deformity PICO #2 Population(s): Children… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/pico-1-populations-children-with-infantile-hemangiomas-ihs-interventions-early-referral-comparators-delayed-referral-outcomess-minimization-of-functional-impairment-andor-cosmetic-deformity-pico-2-populations-children-with
     November 01, 2017 - outcomes to consider include reductions in: Life-threatening complications of IH (i.e. high output cardiac

225. Fatty-Acids-Cardiovascular-Disease Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_research-protocol.pdf
     April 02, 2015 - regular consumption of fish and seafood is associated with lower risk of coronary heart disease and cardiac … Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease … Do omega-3 polyunsaturated fatty acids reduce risk of sudden cardiac death and ventricular arrhythmias … Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: … [mp=ti, ot, ab, nm, hw, kw, kf, px, rx, ui, an, tx, sh, ct, bt, id, cc] 65. exp arrhythmias, cardiac

226. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_executive.pdf
     December 01, 2011 - This phenomenon, characterized by inadequate flow at the cardiac tissue level despite patent coronary … found that use of catheter aspiration, age, and symptom to balloon time were significant predictors of cardiac … Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention … Catheter in Infarct-Related Artery during Primary Percutaneous Coronary Intervention (EXPIRA Trial) on cardiac … is strongly persistent at the end of the washout phase (i.e., dye is strongly persistent after three cardiac

227. Contrast-Induced Nephropathy | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/nephropathy-contrast-induced/research
     January 01, 2020 - reduce the risk of contrast-induced nephropathy (CIN), need for renal replacement therapy, mortality, cardiac

228. Data Points #1: Prevalence of diabetes, diabetic foot ulcer, and lower extremity amputation among Medicare beneficiaries, 2006-2008. | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/diabetes-foot-ulcer-amputation-prevalence/research
     December 01, 2019 - diabetes are expected to suffer from several associated medical complications, such as renal disease, cardiac

229. Management of Suspected Opioid Overdose with Naloxone Guidelines by Emergency Medical Services Personnel | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/emt-naloxon/research-protocol
     August 01, 2019 - result of their central nervous system effects, which cause respiratory depression that can progress to cardiac … questions : Mortality, time to reversal of symptoms, recurrence of overdose symptoms, respiratory or cardiac … outcomes (mortality, time to reversal of symptoms, recurrence of overdose symptoms, respiratory or cardiac

230. Comparative Effectiveness of Treatment for Phenylketonuria | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/phenylketonuria/research-protocol
     December 01, 2019 - affecting outcomes in their infants, including prevention of neurological impairment, microcephaly, and cardiac … affecting outcomes in their infants, including prevention of neurological impairment, microcephaly, and cardiac … outcomes in infant of PKU-affected mother: Prevention of neurologic impairment Prevention of cardiac

231. Diabetes-Foot-Ulcer-Amputation-Incidence Research (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-incidence_research.pdf
     January 01, 2011 - with diabetes often experience sev- eral associated medical complications, such as renal disease, cardiac … are of- ten categorized as microvascular (e.g., nephropathy, retinopathy) and macro- vascular (e.g., cardiac

232. Untitled (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb_surveillance.pdf
     July 06, 2015 - Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart … Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable … Thus the question becomes, At what point following a cardiac revascularization procedure does a patient … trials included in Key Question 1, including HOPE, PEACE, and EUROPA (EURopean trial On reduction of cardiac … Thus the question becomes, At what point following a cardiac revascularization procedure does a patient

233. Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacological Interventions (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-236-maternal-fetal-child-outcomes-disposition-comments.pdf
     April 15, 2021 - please clarify the sixth bullet “Lithium is more likely to be associated with overall congenital and cardiac … yet many clinicians are most likely to use valproic acid when they are fearful of congenital and cardiac … Furthermore, given the lengthy discussion of multiple studies in this section (with 7 studies on cardiac … The discussion of paroxetine and cardiac defects implies that the FDA categorization was incorrect. … We added a small note to indicate that the concern regarding cardiac malformation was at the time of

234. hemangioma-protocol-141223 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_research-protocol.pdf
     December 23, 2014 - congenital anomalies such as PHACES (posterior fossa malformations, hemangiomas, arterial anomalies, cardiac … obstruction • Preservation of vision • Preservation of organ function (e.g., thyroid function, cardiac … obstruction § Preservation of vision § Preservation of organ function (e.g., thyroid function, cardiac … obstruction § Preservation of vision § Preservation of organ function (e.g., thyroid function, cardiac … imperforate anus, and skin tag PHACES: Posterior fossa malformations–hemangiomas–arterial anomalies–cardiac

235. Coronary-Artery-Stenting Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_executive.pdf
     February 01, 2013 - complications (e.g., restenosis, stent thrombosis, and dissection) • Other measures (e.g., findings of cardiac … clinical status (e.g., death, acute MI, repeat revascularization, composite endpoint of major adverse cardiac … reports (83 articles); irrelevant comparators (e.g., intravascular diagnostic techniques compared with cardiac … 0.81 (0.65, 1.01) Long term 3 (587) 0.67 (0.50, 0.90)* 5 (7,700) 0.84 (0.57, 1.25) Major adverse cardiac … IVUS-guided stent placement and stent placement guided by angiography alone for all-cause mortality, cardiac

236. Disseminating Findings From EPC Reports: Pilot Project of Three Products (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-disseminating-findings_0.pdf
     October 01, 2018 - • There was no difference between IOCM and LOCM for secondary outcomes, such as cardiac events, … contrast-induced nephropathy (CIN) • Secondary outcomes: patient characteristics (renal replacement therapy, cardiac

237. Clopidogrel After Drug-Eluting Stent Implantation: Is Current Practice Sufficient? | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/stent-clopidogrel-practice/research
     January 01, 2020 - Collection Baseline Data Baseline demographic, medical history, physical examination and initial cardiac … contemporary patients receiving percutaneous coronary intervention, the long-term risk for death and major cardiac … Acknowledgments We acknowledge the commitment of faculty and staff of the cardiac catheterization laboratories

238. Migraine patients in the ER receive various IV medications from different ER doctors within the physician group. As I have watched particular drug combinations given to my patients and to my daughter in the ER, I have witnessed total… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/migraine-patients-in-the-er-receive-various-iv-medications-from-different-er-doctors-within-the-physician-group-as-i-have-watched-particular-drug-combinations-given-to-my-patients-and-to-my-daughter-in-the-er-i-have-witnesse
     November 01, 2017 - no If yes, please explain: Like universal treatment for cardiac chest pain, migraines and other

239. Disposition of Comments CER 219 Antipsychotics for the Prevention and Treatment of Delirium (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/delirium-disposition-comments.pdf
     September 03, 2019 - haloperidol or second-generation antipsychotics used for the prevention or treatment of delirium, but cardiac … Evidence Summary > Adverse Effects: Consider opening this section with a short summary of adverse cardiac … more text in the discussion (particularly the executive summary) into the sub-populations studied (cardiac … One part of the document notes that post- operative patients had had hip surgery, GI surgery, and cardiac

240. Use of Natriuretic Peptide Measurement in the Management of Heart Failure | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/heart-failure-natriuretic-peptide/research-protocol
     December 01, 2019 - could be used for diagnosis in acute and non-acute settings, its prognostic value for HF and other cardiac … there was consistent evidence that BNP and NT-proBNP were independent predictors of mortality and other cardiac … 2005 4,14 have evaluated the evidence that BNP and NT-proBNP are predictive of mortality and other cardiac … How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure